参考文献
[1]中国高血压防治指南修订委员会.中国高血压防治指南2010.中华心血管病杂志，2011，39：579-616.
[2]家庭血压监测中国专家共识.中华高血压杂志，2012，20：525-529.
[3]Mancia G,Laurent S,Agabiti-Rosei,et al.Reappraisal of European guidelines on hypertension management:a European Society of Hypertension Task Force document.J Hypertens,2009,27:2121-2158.
[4]Krause T,Lovibond K,Caulfield M,et al.Guidelines Development Group.Management of hypertension:summary of NICE guidance.BMJ,2011,343:d4891.
[5]Sleight P,Redon J,Verdecchia P,et al.Prognostic value of blood pressure in patients with high vascular risk in the Ongoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial study.J Hypertens,2009,27:1360-1369.
[6]Messerli FH,Panjrath GS.The J-curve between blood pressure and coronary artery disease or essential hypertension:exactly how essential?J Am Coll Cardiol,2009,54:1827-1834.
[7]Cushman WC,Evans GW,Byington RP,et al.Effects of intensive blood-pressure control in type 2diabetes mellitus.N Engl J Med,2010,362:1575-1585.
[8]Law MR,Morris JK,Wald NJ.Use of blood pressure lowering drugs in the prevention of cardiovascular disease:meta-analysis of 147 randomised trial in the context of expectations from prospective epidemiological studies.BMJ,2009,338:b1665.
[8]Zhang L,Miyaki K,Wang W,et al.CYP3A5 Polymorphism and sensitivity of blood pressure to dietary salt in Japanese men.J Hum Hypertens,2010,24:345-350.(https://www.daowen.com)
[10]Grassi G.The ROADMAP trial:olmesartan for the delay or prevention of microalbuminuria in type 2diabetes.Expert Opin Pharmacother,2011,12:2421-2424.
[11]Haller H,Ito S,Izzo JL Jr,et al.Olmesartan for the delay or prevention of microalbuminuria in type 2diabetes.N Engl J Med,2011,364:907-917.
[12]Wang JG,Kario K,Lau T,et al.Use of the dihydropyridine calcium channel blockers in the management of hypertension in Eastern Asians:a scientific statement of the Asian Pacific Heart Association.Hypertens Res,2011,34:423-430.
[13]Tsara V,Amfilochiou A,Papagrigorakis MJ,et al.Guidelines for diagnosis and treatment of sleeprelated breathing disorders in adults and children.Definition and classification of sleep related breathing disorders in adults:different types and indications for sleep studies(Part 1).Hippokratia,2009,13:187-191.
[14]Raju N,Sobieraj-Teague M,Hirsh J,et al.Effect of aspirin on mortality in the primary prevention of cardiovascular disease.Am J Med,2011,124:621-629.
[15]Fan HQ,Li Y,Thijs L,et al.On behalf of theinternational database on ambulatory blood pressure in relation to cardiovascular outcomes(IDACO)investigators.Prognostic value of isolated nocturnal hypertension in 8,711 subjects from 10 populations.J Hypertens,2010,28:2036-2045.
[16]Li Y,Thijs L,Hansen TW,et al.On behalf of the international database on ambulatory blood pressure in relation to cardiovascular outcomes(IDACO)investigators.Prognostic value of the morning blood pressure surge in 5,645 subjects from 8 populations.Hypertension,2010,55:1040-1048.
[17]Hansen TW,Thijs L,Li Y,et al.On behalf of the international database on ambulatory blood pressure in relation to cardiovascular outcomes(IDACO)investigators.Prognostic value of short-term blood pressure variability over 24 hours in 8,937 subjects from 11 populations.Hypertension,2010,55:1049-1057.